Treatment of neurodegenerative diseases and cancer of the brain

Details for Australian Patent Application No. 2002340253 (hide)

Owner Sloan-Kettering Institute for Cancer Research

Inventors Marks, Paul A; Richon, Victoria M; Rifkind, Richard A

Agent Cullen & Co

Pub. Number AU-B-2002340253

PCT Number PCT/US02/33246

PCT Pub. Number WO2003/032921

Priority 60/329,705 16.10.01 US

Filing date 16 October 2002

Wipo publication date 28 April 2003

Acceptance publication date 27 October 2005

International Classifications

A61K 031/47 - Quinolines

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/329,705 16.10.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002340253

27 October 2005 Application Accepted

  Published as AU-B-2002340253

23 February 2006 Standard Patent Sealed

2 December 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 10 Nov 2010. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000

31 March 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 10 Nov 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002340254-SPRAY GUN WITH VARIABLE LOAD LINE CONTROL

2002340252-DEPLOYMENT OF BUSINESS LOGIC SOFTWARE AND DATA CONTENT ONTO NETWORK SERVERS